Tag: antibody

Eli Lilly and Co Awarded $312.5M Contract For Procurement Of Monoclonal Antibody Therapeutic LY-CoV555

Posted on by Eric Coffie

Eli Lilly and Co., Indianapolis, Indiana, was awarded a $312,500,000 firm-fixed-price contract for procurement of monoclonal antibody therapeutic LY-CoV555. Bids were solicited via the internet with one received. Work will be performed in Indianapolis, Indiana, with an estimated completion date of June 30, 2021. Fiscal 2021 Coronavirus Aid, Relief, and Economic Security (CARES) Act funds in the amount of $312,500,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-21-C-0016). (Awarded Oct. 27, 2020)

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products. (www.bloomberg.com)

AstraZeneca Awarded $60M Contract To Manufacture Antibody Products

Posted on by Eric Coffie

AstraZeneca, Gaithersburg, Maryland, was awarded a $60,000,000 firm-fixed-price contract to manufacture AZD7442, a combination antibody product intended to prevent or treat clinical effects of SARS-CoV-2, for a minimum of 100,000 treatment courses. Work will be performed in Gaithersburg, Maryland, with an estimated completion date of June 30, 2021. Fiscal 2020 Army general funds in the amount of $30,000,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-20-C-0119). (Awarded Sept. 30, 2020)

AstraZeneca Pharmaceuticals (AstraZeneca US), a subsidiary of UK-based global drugmaker AstraZeneca, is a significant player in the US pharmaceuticals market. The company’s sales represent about a third of its parent’s revenues. AstraZeneca US’ treatments focus on several therapeutic areas: cardiovascular, renal, metabolic, oncology, and respiratory disorders. Its best-known products include asthma medicine Symbicort; cancer drugs Tagrisso, Faslodex, and Imfinzi; and cardiovascular treatments Brilinta and Farxiga (cardiovascular). The company operates several R&D and manufacturing locations across the US.(dnb.com)